Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Research ArticleResearch

Benchmarking of Sterilizing-Grade Filter Membranes with Liposome Filtration

Bhuwan Singh, Ramesh Mundlamuri, Thomas Friese, Ashok Mundrigi, Sebastian Handt and Thomas Loewe
PDA Journal of Pharmaceutical Science and Technology May 2018, 72 (3) 223-235; DOI: https://doi.org/10.5731/pdajpst.2017.007757
Bhuwan Singh
1Sartorius Stedim India Pvt Ltd., Bangalore, India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramesh Mundlamuri
3Panacea Biotech Limited, Punjab, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Friese
2Sartorius Stedim biotech GmbH, Göttingen, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashok Mundrigi
1Sartorius Stedim India Pvt Ltd., Bangalore, India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Handt
2Sartorius Stedim biotech GmbH, Göttingen, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Loewe
2Sartorius Stedim biotech GmbH, Göttingen, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Thomas.loewe@sartorius-stedim.com
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Cytotoxic drugs can be encapsulated in liposomes vesicles, which act as drug delivery vehicles and reduce the risk of exposure of drug to healthy cells. The sterility of such liposome solutions is typically ensured using 0.2 μm–rated sterilizing-grade membranes, but due to the high viscosity and low surface tension of these formulations, they can cause premature blocking and increased risk of bacterial penetration through a 0.2 μm sterilizing-grade membrane. The low surface tension of liposome solutions affects the contact angle with membrane and reduces bubble point, leading to bacterial penetration through the membrane. This poses a great challenge to select an appropriate sterilizing-grade membrane for a given process and for filter manufacturers to develop a sterilizing-grade membrane that specifically addresses these needs. In this study, the influence of different variables that could affect the total throughput and bacterial retention performance of different membrane types on processing of liposome solutions was evaluated. Based on the results, we conclude that the membrane properties, for example, surface porosity, surface tension, pore size, symmetry/asymmetry, hydrophilicity and liposome properties (e.g., composition, lipid size, and concentration) affect bacterial retention and total throughput capacity. Process parameters such as temperature, pressure, and flow should also be optimized to improve process efficiency.

LAY ABSTRACT: Cytotoxic drugs can be encapsulated in liposomes vesicles, which act as drug delivery vehicles and reduce the risk of exposure of drug to healthy cells. Liposome solution cause premature blocking and increased risk of bacterial penetration through a 0.2 μm sterilizing-grade membrane due to their high viscosity and low surface tension. In this study, we demonstrated the total throughput and bacterial retention performance of different sterilizing-grade membranes with liposome solution. Based on the results, we conclude that some sterilizing-grade membranes yield less throughput and bacterial retention compared to other membranes. This is due to liposome formulation and membrane properties. Therefore, it is important to identify the product formulation and membrane properties before selection of a suitable sterilizing-grade filter for a given process application to ensure expected throughput and bacterial retention.

  • Cytotoxic drugs
  • Adjuvants
  • Liposomes
  • Drug delivery
  • Bacterial retention
  • Hydrophilic membrane
  • Vaccines
  • mAbs

Introduction

Cytotoxic drugs can be encapsulated in liposomes vesicles, which act as drug delivery vehicles and reduce the risk of exposure of drug to healthy cells (1). The sterility of such liposome solutions is typically ensured using 0.2 μm–rated sterilizing-grade membranes, but due to the high viscosity and low surface tension of these formulations, they can cause premature blocking and increased risk of bacterial penetration through a 0.2 μm sterilizing-grade membrane (2). The low surface tension of liposome solutions affects the contact angle with membrane and reduces bubble point, leading to bacterial penetration through the membrane. This poses a great challenge to select an appropriate sterilizing-grade membrane for a given process and for filter manufacturers to develop a sterilizing-grade membrane that specifically addresses these needs.

Adjuvants are commonly used in vaccine and other drug formulations to enhance the immune response to an antigen and to increase the therapeutic response. Novel adjuvants are often based on emulsions or liposomes, which are suspensions of small droplets made up of surfactant or lipid particles. In general, liposomes are lipid vesicles used as vehicles for the administration of cytotoxic drugs with enhanced clinical efficacy and reduced toxicity (3). Unlike micelles that encapsulate the drug with a single lipid monolayer, liposomes contain phospholipids and cholesterols as their components that form a phospholipid bilayer, which encases the drug (4) (Figure 1).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Structure of liposome.

Liposomes exist as either small unilamellar or multilamellar vesicles, and their size usually varies from 20 nm to 3 μm. The external surface of liposome vesicles can be modified to enhance the attachment of liposome vesicles to target sites for drug delivery. There are three generations of liposomes that can be identified based on their surface modifications:

  1. First Generation Liposomes: These are conventional liposomes and are non-PEGylated.

  2. Second Generation Liposomes: These are PEGylated liposomes with reduced toxicity.

  3. Third Generation Liposomes: PEGylated liposomes with targeted ligands on their surface.

In this study, filterability and bacterial retention trials were conducted with different sterilizing-grade membranes from different membrane manufacturers using a non-PEGylated liposome solution prepared by an independent laboratory.

Materials and Methods

Materials

1. Test Membranes:

Shown in Table 1.

View this table:
  • View inline
  • View popup
TABLE I

List of Single-Use Pleated Membranes [Effective Filtration Area (EFA) = 150–230 cm2]

2. Membrane Specifications:

Shown in Table 2.

View this table:
  • View inline
  • View popup
TABLE II

Pore Size Rating and Membrane Configurations

3. Media and Chemicals.

View this table:
  • View inline
  • View popup
TABLE III

List of Media and Chemicals

4. Liposome Solution:

The liposome solution used for throughput studies was a non-PEGylated, multilamellar liposome having size of 0.05–0.1 μm and composed of cholesterol and 1, 2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE). The liposome solution was pre-filtered through a Sartoclean (3 μm + 0.8 μm)-rated two-layer membrane filter and used for the trials. This pre-filtration removed large multilamellar vesicle aggregates and provided a uniform distribution of liposome molecules. For filterability and bacterial retention studies, the liposome solution was diluted to 10 mg/mL using an isotonic solution of sucrose and ammonium sulphate. The liposome solution was diluted to 10 mg/mL in order to have more filtrate volume and therefore reduce systematic errors, as high concentrations of liposome cause premature blocking of membranes.

Methods

1. Surface Porosity Measurement:

The surface porosity of both 0.1 μm– and 0.2 μm–rated sterilizing-grade membranes (Table I) was determined. The surface porosity of a membrane indicates the number of open pores available on the upstream surface of membrane. The measurement was done using the image-processing software “Scandium”. This image-processing software was used in conjugation with a scanning electron microscopy (SEM) image of the membrane to convert the image into red and green areas. The green area represents membrane pores, and the red area is the the solid polymer structure of the membrane. The software measures the percentage of red and green area in the polymer, and the percentage of the green area is referred to as the surface porosity of the membrane. The color combination of area can be changed in the Scandium software as shown in Figure 2 with the red and green areas.

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

Estimation of surface porosity using Scandium image processing software.

2. Surface Tension Measurement:

The surface tension of all membranes (Table I) was measured; this represents the variation in intermolecular forces of molecules on the membrane surface. Surface tension measurement is done by the calcium chloride drop test method. Each concentration of calcium chloride salt solution has a defined surface tension at 25 °C temperature as given in Table IV.

View this table:
  • View inline
  • View popup
TABLE IV

Standard Calcium Chloride Concentration versus Surface Tension

A drop of a particular concentration of calcium chloride with respective surface tension is placed on the membrane, and the concentration of calcium chloride that wets the membrane immediately is considered as the surface tension of the membrane.

3. Bubble Point Measurement:

The integrity of membranes was evaluated in terms of the bubble point test using a Sartocheck® integrity tester. In brief, the bubble point test is performed on wet filter membranes where the wetting liquid is held inside the porous structure by capillary forces. This force increases as the pore size decreases. A specific gas pressure dependent on the pore size of the membrane is necessary to force out the liquid from the pores. This is called the bubble point. The test parameters for bubble point measurement of each membrane type are given in Table V.

View this table:
  • View inline
  • View popup
TABLE V

Test Parameters for the Bubble Point Test

4. Water Flow Rate Measurement:

Water flow rate was measured for each membrane type by using reverse osmosis (RO) water. The test membrane was connected after flow meter and flow rate was performed at a differential pressure of 1.0 bar in duplicate measurements. The test membrane was wetted for 5 min at 0.3 bar differential pressure before flow measurement to ensure no air bubbles are entrapped in membrane pores which can influence the water flow measurement.

5. Throughput Test Method:

The throughput of both 0.1 μm and 0.2 μm sterilizing-grade membranes was evaluated at a constant pressure of 2.0 bar using single-use process-scale pleated membrane devices [effective filtration area (EFA): 150–230 cm2]. The criterion for defining membrane blocking was when the flow rate dropped to below 20% of the initial flow. All the data was collected by using the multi-total throughput system shown in Figure 3.

Figure 3
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3

Test setup for throughput studies.

6. Bacterial Challenge Test (BCT) Method:

• Preparation of Test Culture

A Brevundimonas diminuta culture ATCC No 19146 was prepared by inoculating 1 mL of pre-culture in 100 mL of saline lactose broth (SLB) medium and incubating for 24 h at 30 ± 2 °C. The optical density (OD) of the suspension was measured using a spectrophotometer at 590 nm to ensure a minimum of 5 × 108 cfu/mL. This was used as the bacterial test suspension.

• Bacterial Challenge Test (BCT)

Prior to the BCT, a viability test was performed over a 30 min interval to confirm the viability of B. diminuta in liposome solution. Bacterial challenge test was performed in duplicates in single-pass filtration mode at room temperature (25 ± 2 °C) and at a differential pressure of 0.5 bar using a peristaltic pump. The pressure was monitored using manometers. All test membranes were single-use pleated devices (150–230 cm2) and were challenged with 1 × 107 cfu/cm2 using the BCT setup as depicted in Figure 4.

Figure 4
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4

Test setup for the bacterial challenge test (BCT).

The filtrate was collected in a sterile flask. Each membrane was flushed with 5 L per 150 cm2 membrane area using 1× phosphate-buffered saline (PBS) buffer after the BCT to remove the product from the membrane followed by water flushing. This was performed so that the product does not interfere with the bubble point measurement of membranes post-BCT. The test equipment for flushing is illustrated in Figure 5.

Figure 5
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5

Flushing setup for the bacterial challenge test (BCT).

A sample was collected from the challenge suspension reservoir upstream of the test membrane to determine the titer pre- and post-challenge. A sample of main culture suspension was also evaluated for cell dispersion. The analysis membranes were aseptically transferred on tryptic soy agar (TSA) plates and incubated at 30 ± 2 °C for 3–5 days. The post-BCT bubble point of the test membrane was determined.

Results

1. Surface Porosity Measurement

The upstream surface porosity of each membrane combination, which includes the first layer and second layer of membrane, was calculated in terms of percentage surface porosity using the image-processing Scandium software and is given in Table VI.

View this table:
  • View inline
  • View popup
TABLE VI

Percentage Surface Porosity of Membrane Combination

In order to receive a parameter considering both membranes of a dual-layer membrane combination, a mean porosity of the two respective layers was calculated. The surface porosity of membrane combination is highest in Membrane H followed by Membranes G, B, C, A, E, F, and D (Table VI).

2. Surface Tension Measurement

The surface tension of membranes was measured using the calcium chloride drop test method, and the results are summarized in Table VII in terms of millinewtons per meter (mN/m).

View this table:
  • View inline
  • View popup
TABLE VII

Surface Tension of Membrane Combination

In order to receive a parameter considering both membranes of a dual-layer membrane combination, a mean surface tension of the two respective layers was calculated. Membranes A, B, and C have overall low surface tension compared to Membranes D, E, F, G, and H (Table VII). Hydrophilic surface modifications increase the surface tension of the membranes irrespective of their material of construction. Therefore, Membranes D, E, F, G, and H, which are surface-modified, have higher surface tension in comparison to Membranes A, B, and C, which are not surface-modified. As we measure the surface tension of membrane with defined concentrations of calcium chloride, we observe that surface-modified membranes (higher hydrophilicity) are spontaneously wettable within 1 s by higher concentrated calcium chloride solutions than non-surface-modified membranes (lower hydrophilicity). The higher the concentration of the calcium chloride salt solution that is able to spontaneously wet the membrane, the higher the hydrophilicity of the sample membrane. It is a qualitative test, which is useful to identify trends between different membrane samples.

3. Bubble Point Measurement

Bubble point measurement of test membranes was performed at 25 °C using RO water as a wetting medium. The bubble point values were measured with Sartocheck® integrity tester. The bubble point values are illustrated in Table VIII.

View this table:
  • View inline
  • View popup
TABLE VIII

Bubble Point (bar) of Membrane Combinations

The bubble point value of each membrane was correlated to the mean flow pore size value. The mean flow pore size is determined by applying gas pressure to the upstream side of a liquid-filled membrane, said gas pressure gradually displaces the liquid from the pores, and increasing gas flow occurs at increasing gas pressure, which is measured versus the pore size. The mean flow pore size is the pores size of mean flow occurring in this test procedure. The mean flow pore sizes and the nominal pore sizes of the membranes are given in Table IX.

View this table:
  • View inline
  • View popup
TABLE IX

Mean Flow Pore Size (μm) of Membrane Combinations

As the bubble point increases, the mean flow pore size decreases because the membrane pore diameter decreases and membrane pores become tighter (Tables VIII and IX). For example, Membrane C has least mean flow pore size value of 0.204 μm in the second layer compared to other membrane types, and it has the highest bubble point value of >6.0 bar (Table VIII).

4. Water Flow Rate Measurement

Water flow rate of each membrane type was measured at a differential pressure of 1.0 bar using a liquid flow meter, and flow was normalized to LMH (liters per square meter) as given in Figure 6.

Figure 6
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6

Water flow rate of 0.1 μm and 0.2 μm sterilizing-grade membrane combination at 20 °C.

Membrane B exhibits the highest water flow rate compared to other membrane types, whereas Membrane C display lowest flow rate. Water flow rate depends upon the hydrodynamic resistance caused by the membrane combination (Figure 6).

5. Filterability Studies

Initial throughput feasibility studies were conducted using a 34 mg/mL concentration of liposome solution and caused premature blocking (data not shown here). Therefore, the solution was diluted using an isotonic solution of sucrose and ammonium sulphate to 10 mg/mL concentration and used for throughput trials. Throughput studies were performed using seven different 0.2 μm–rated and one 0.1 μm–rated sterilizing-grade membranes at a constant pressure of 2.0 bar. The filtrate data was collected using Multi Total Throughput Software at 80% blocking criteria, and normalized throughput data in terms of kilograms per square meter (kg/m2) is depicted in Figure 7.

Figure 7
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7

Total throughput of 0.1 μm and 0.2 μm sterilizing-grade membrane combination with liposome (10 mg/mL).

As depicted in Figure 7, Membrane H yields highest throughput followed by Membrane B and Membrane G when filtering a 10 mg/mL liposome solution. Membranes H, G, and B have high throughput results with liposome solution due to high surface porosity of their membrane combinations. Membrane H yields 19% high throughput compared to Membrane G because of 3% higher surface porosity (38%) in Membrane H compared to Membrane G (35%) in the 0.2 μm–rated membrane combinations. In contrast, Membrane B yields the next highest throughput although the surface porosity of Membrane B is 24%.This enhanced throughput in Membrane B is due to its largest pore-rated 0.8 μm first-layer membrane. This indicates that high surface porosity and a large pore size-rated first layer membrane of a sterilizing-grade membrane combination help in increasing throughput capacity with liposome-based formulations. However, no significant effect of membrane configurations (Table II) was observed in enhancing throughput with liposome solution. For example, membrane E yields up to 87% lesser throughput compared to Membrane B, G, and H even though it has a highest grade of 0.5 μm–rated asymmetric first-layer membrane. Furthermore, Membrane C, a 0.1 μm–rated membrane, yields comparable throughput to 0.2 μm–rated Membranes E and F due to high surface porosity in its membrane combination (21%), which is similar to the surface porosity (20%) of Membranes E and F.

Bacterial Retention Studies

The BCT was conducted with seven different 0.2 μm and one 0.1 μm sterilizing-grade pleated membranes (EFA 150–230 cm2) using 10 mg/mL liposome solution in single-pass filtration mode to reach a minimum challenge level of 1 × 107 cfu/cm2 at a differential pressure of 0.5 bar. The bacterial retention performance was calculated in terms of log reduction value (LRV), as depicted in Figure 8.

Figure 8
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 8

Bacterial retention of 0.1 μm and 0.2 μm sterilizing-grade membrane combinations with liposome (10 mg/mL).

Membranes A, B, C, and E provided 100% bacterial retention with LRV ≥8, whereas bacterial breakthrough was observed with membranes D, F, G, and H (Figure 8).The high hydrophilicity caused by surface modifications in Membranes D, F, G, and H correlates to the bacterial breakthrough. The effect of hydrophilicity in membrane is further confirmed by the retention performance of membrane D, which has the same polymer as Membrane A but failed in retaining bacteria unlike Membrane A because Membrane D is surface-modified and Membrane A is unmodified.

The bacterial retention of surface modified Membrane E with LRV 8.2 is due to its lower pore size of the second-layer retentive membrane, which is evident from its high bubble point and low mean flow pore size values (Table VIII and Table IX). This suggests that hydrophilicity and mean flow pore size of membranes play a significant role in bacterial retention with liposome-based formulations. Furthermore, each membrane was flushed with a defined volume of buffer followed by water after the BCT to recover the original bubble point, and the bubble point was measured to ensure the integrity of membranes, as shown in Figure 9.

Figure 9
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 9

Bubble point of 0.1 μm and 0.2 μm sterilizing-grade membranes after flushing.

Membranes A, B, D, E, G, and H recovered 100% of their original bubble point values, while Membrane C and F recovered 92% and 95%, respectively, which ensures their integrity after the BCT as presented in Figure 9.

Discussion

Filterability Studies

Initial throughput feasibility studies were conducted using a 34 mg/mL concentration of liposome solution (data not shown). Due to high lipid content, it resulted in low throughput and caused premature blocking, which means throughput capacity also depends on the liposome concentration being used. Therefore, a diluted liposome solution of 10 mg/mL concentration was used for further trials. The throughput capacity is dependent on membrane configurations, the pore size rating of the first layer (Table II), and the mean surface porosity of membrane combination (Table VI) with liposome-based formulations. The correlation of pore rating and surface porosity of membrane combination is presented in Figure 10.

Figure 10
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 10

Correlation of throughput with pore rating and percentage surface porosity.

It is observed that Membranes B, G, and H with symmetric membrane combination display high-throughput performance compared to other membrane types (Figure 10). The high-throughput performance of Membranes G and H is due to high mean surface porosity of membrane combinations (Figure 10). The high throughput achieved with Membrane B is due to the largest 0.8 μm pore–rated first-layer membrane apart from the high surface porosity of membrane combination (24%).This large pore–rated first-layer membrane traps the large aggregates of liposomes and protects the second layer of membrane from premature blocking. This suggests that the higher pore–rated-first layer and high surface porosity of membrane combination enhance the throughput capacity with liposome-based formulations.

Bacterial Retention Studies

Bacterial retention through a membrane is dependent on the second layer of membrane combination, which defines the absolute rating of sterilizing-grade membranes. The bacteria retention with liposome solution depends upon the pore size of the second layer of membrane and the hydrophilicity of the membrane combination. The pore size of a membrane is measured in terms of its bubble point (Table VIII), and the hydrophilicity is measured in terms of the surface tension of the membrane combination (Table VII). The bubble point is further correlated with the mean flow pore size (Table IX) of the second layer of the membrane and is inversely proportional. It was observed that some of the 0.2 μm–rated sterilizing-grade membranes did not provide complete bacteria retention with liposome solution (Figure 8) even though the diameter of B. diminuta is 0.2–0.3 μm (5). The correlation of bacteria retention in terms of LRV with the bubble point of the second layer of the membrane combination is given in Figure 11.

Figure 11
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 11

Bubble point versus LRV of the second layer of membrane combination.

The second layer of membrane combinations of Membranes A, B, and D have a bubble point value of 3.75 bar. The complete retention of B. diminuta was observed with unmodified membrane A and B with LRV ≥7 (Figure 11), unlike surface-modified membrane D, which is made of the same polymer as Membrane A and failed in retaining bacteria (LRV = 6.3) during liposome filtration. This is because of less hydrophilicity in unmodified Membranes A and B with relatively low surface tension values (75 mN/m) compared to surface-modified Membrane D, which has high hydrophilicity with high surface tension value of (79 mN/m) in the membrane combination. Similarly, surface-modified Membranes F, G, and H were not able to retain bacteria completely because they have a lower bubble point and high hydrophilicity (Figure 11). However, surface-modified Membrane E provided complete bacterial retention due to its high bubble point value (5 bar) and lower mean flow pore size value (0.27μm). The unmodified Membrane C also retained bacteria due to its high bubble point value (6 bar) and lower mean flow pore size (0.20 μm). Furthermore, liposome vesicles are made up of phospholipid molecules, which are amphipathic in nature, having a hydrophilic phosphate head and hydrophobic fatty acid tail (Figure 1). This hydrophilic phosphate group of the liposome molecule is oriented outside and makes a weak interaction with the membrane surface. These interactions cause adsorption of liposome vesicles to the surface of modified hydrophilic membranes and leads to slipping of bacteria from the membrane surface that allows bacterial penetration. The liposome vesicle and bacteria undergo competitive binding to the membrane interface. The liposomes undergo stronger adsorption to the membrane surface compared to bacteria, and the slipping of bacteria occurs due to repulsion between phosphate groups of the phospholipid bilayer of bacteria oriented outside with the phosphate group of the liposome molecules. This suggests that bubble point of the second layer and hydrophilicity of a membrane combination play an important role in bacterial retention with liposome-based formulations.

In summary, the total throughput and bacterial retention performance of different 0.1 μm and 0.2 μm sterilizing-grade membranes with 10 mg/mL concentration of liposome solution is presented in Figure 12.

Figure 12
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 12

Throughput versus bacterial retention of 0.1 μm and 0.2 μm sterilizing-grade membranes with liposome (10 mg/mL).

From the above studies of different 0.1 μm– and 0.2 μm–rated sterilizing-grade membranes, Membrane B provides the best combination of bacterial retention and total throughput for adjuvant and liposome-based solutions used in vaccine and drug manufacturing industries (Figure 12). The enhanced total throughput in membrane B is due to its largest 0.8 μm pore–rated first layer and comparable surface porosity (24%) in the membrane combination, whereas the bacterial retention is due to its less hydrophilicity in the membrane combination.

Conclusion

Based on the above results, it is concluded that the total throughput capacity of a membrane with liposome solution depends upon the largest size pore rating of the first layer and high surface porosity of the membrane combination irrespective of membrane configurations, and the bacterial retention performance of a membrane depends upon the hydrophilicity and tighter pore size of the second layer of the membrane combination.

However, successful sterilizing filtration validation with liposome-based formulations also requires a careful control of following parameters early in process design; these were not evaluated in this process solution:

  1. Process solution: properties of liposome, for example, concentration, lipid content, and surface tension.

  2. Bacteria type: properties of bacteria, for example, size, motility, viability in liposome solution.

  3. Process parameters: pressure, flow rate, and temperature.

Conflict of Interest Declaration

None of the authors has a financial or other conflict of interest.

Acknowledgements

The authors thank Mr. Nick Hutchinson, technical writer, Sartorius Stedim biotech. GmbH for technical review of manuscript.

  • © PDA, Inc. 2018

Reference

  1. 1.↵
    1. Connor T. H.,
    2. McDiarmid M. A.
    Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings. CA: A Cancer Journal for Clinicians 2006, 56 (6), 354–365.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Biopharma International Editors. Optimizing Adjuvant Filtration; Mike Tessalone: New York, 2012; Vol 25 (Issue 4).
  3. 3.↵
    1. Brown F.,
    2. Haaheim L. R.,
    3. Bomford R.
    Modulation of the Immune Response to Vaccine Antigens. In Will Adjuvants Be Needed for Vaccines of the Future? Karger: Basel, Switzerland, 1998; Vol 92, pp 8–13.
    OpenUrl
  4. 4.↵
    1. ElBayoumi T. A.,
    2. Torchilin V. P.,
    3. Weissig V.
    Current Trends in Liposome Research. In Liposomes Methods and Protocols; Humana Press: New York, 2010; Vol 1, pp 1–27.
    OpenUrl
  5. 5.↵
    1. Lee S. H.,
    2. Lee S.,
    3. Kim C. W.
    Changes in the Cell Size of Brevundimonas diminuta Using Different Growth Agitation Rates. PDA J. Pharm. Sci. Technol. 2002, 56 (2), 99–108.
    OpenUrlAbstract/FREE Full Text
  6. 6.
    New South Wales (NSW) Government. Cytotoxic Drugs and Related Waste Guide, 2nd ed.; Australia, 2008.
  7. 7.
    FDA Guidance for Industry. Sterile Drug Products Produced by Aseptic Processing, 2004.
  8. 8.
    1. Cullis P. R.,
    2. de Kruijff B.
    Lipid Polymorphism and the Functional Roles of Lipids in Biological Membranes. Biochim. Biophys. Acta 1979, 559 (4), 399–420.
    OpenUrlCrossRefPubMed
  9. 9.
    1. Weissig V.
    Liposomes Methods and Protocols. In Pharmaceutical Nanocarriers; Humana Press: New York, 2010; Vol. 1.
  10. 10.
    1. Sundaram S.,
    2. Lewis M.,
    3. Eisenhuth J.,
    4. Howard G. J.,
    5. Larson B.
    Method for Qualifying Microbial Removal Performance of 0.1 Micron Rated Filters. Part IV: Retention of Hydrogenophaga pseudoflava (ATCC 700892) and Ralstonia pickettii (ATCC 700591) by 0.2 and 0.22 Micron Rated Filters. PDA J. Pharm. Sci. Technol. 2002, 56 (3), 150–171.
    OpenUrlAbstract/FREE Full Text
  11. 11.
    1. Torchilin V. P.
    Recent Advances with Liposomes as Pharmaceutical Carriers. Nat. Rev. Drug Discov. 2005, 4 (2), 145–160.
    OpenUrlCrossRefPubMed
  12. 12.
    1. Folmsbee M.,
    2. Moussourakis M.
    Sterilizing Filtration of Liposome and Related Lipid-Containing solutions: Enhancing Successful Filter Qualification. PDA J. Pharm. Sci. Technol. 2012, 66, 161–167.
    OpenUrlAbstract/FREE Full Text
  13. 13.
    PDA Technical Report No 26. Sterilizing Filtration of Liquids. PDA J. Pharm. Sci. Technol. 2008, 62 (Suppl 5), 1–60.
    OpenUrlAbstract/FREE Full Text
  14. 14.
    American Society for Testing and Materials (ASTM). ASTM Standard F838-05. Standard Test Method for Determining Bacterial Retention of Membrane Filters Utilized for Liquid Filtration, 2005.
  15. 15.
    1. Onraedt A.,
    2. Folmsbee M.,
    3. Kumar A.,
    4. Martin J.
    Sterilizing Filtration of Adjuvanted Vaccines: Ensuring Successful Filter Qualification. BioPharm Int. 2010, October.
  16. 16.
    1. Sharma U. S.,
    2. Sharma A.
    Liposomes in Drug Delivery: Progress and Limitations. Int. J. Pharm. 1997, 154 (2), 123–140.
    OpenUrlCrossRef
  17. 17.
    1. Toh M.-R.,
    2. Chiu G. N. C.
    ; Liposomes as Sterile Preparations and Limitations of Sterilization Techniques in Liposomal Manufacturing. Asian J. Pharm. Sci. 2013, 8 (2), 88–95.
    OpenUrl
  18. 18.
    1. Cevc G.
    Lipid Vesicles and Other Colloids as Drug Carriers on the Skin. Adv. Drug Deliv. Rev. 2004, 56 (5), 675–711.
    OpenUrlCrossRefPubMed
  19. 19.
    1. Helling A.,
    2. Kubicka A.,
    3. Schaap I. A. T.,
    4. Polakovic M.,
    5. Hansmann B.,
    6. Thiess H.,
    7. Strube J.,
    8. Thom V.
    Passage of Soft Pathogens through Microfiltration Membranes Scales with Transmembrane Pressure. J. Membr. Sci. 2016, 522, 292–302.
    OpenUrl
  20. 20.
    1. Holme M. N.,
    2. Fedotenko I. A.,
    3. Abegg D.,
    4. Althaus J.,
    5. Babel L.,
    6. Favarger F.,
    7. Reiter R.,
    8. Tanasescu R.,
    9. Zaffalon P. L.,
    10. Ziegler A.,
    11. Müller B.,
    12. Saxer T.,
    13. Zumbuehl A.
    Shear-stress Sensitive Lenticular Vesicles for Targeted Drug Delivery. Nat. Nanotechnol. 2012, 7 (8), 536–543.
    OpenUrlCrossRefPubMed
  21. 21.
    1. Kaesler I.,
    2. Haake G,
    3. Hennig H.,
    4. Rosenhagen A.,
    5. Meltzer T.,
    6. Jornitz M.
    The Importance of Accurate Microorganism Identification in Microbial Challenge Tests of Filter Membranes—Part I. PDA J. Pharm. Sci. Technol. 2011, 65 (2), 92–99.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 72 (3)
PDA Journal of Pharmaceutical Science and Technology
Vol. 72, Issue 3
May/June 2018
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Benchmarking of Sterilizing-Grade Filter Membranes with Liposome Filtration
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Benchmarking of Sterilizing-Grade Filter Membranes with Liposome Filtration
Bhuwan Singh, Ramesh Mundlamuri, Thomas Friese, Ashok Mundrigi, Sebastian Handt, Thomas Loewe
PDA Journal of Pharmaceutical Science and Technology May 2018, 72 (3) 223-235; DOI: 10.5731/pdajpst.2017.007757

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Benchmarking of Sterilizing-Grade Filter Membranes with Liposome Filtration
Bhuwan Singh, Ramesh Mundlamuri, Thomas Friese, Ashok Mundrigi, Sebastian Handt, Thomas Loewe
PDA Journal of Pharmaceutical Science and Technology May 2018, 72 (3) 223-235; DOI: 10.5731/pdajpst.2017.007757
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Conflict of Interest Declaration
    • Acknowledgements
    • Reference
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Optimizing the Filtration of Liposomes Using Sterilizing-Grade Filters
  • Google Scholar

More in this TOC Section

  • A proof-of-concept study on a universal standard kit to evaluate the risks of inspectors for their foundational ability of visual inspection of injectable drug products
  • Definition of Particle Visibility Threshold in Parenteral Drug Products—Towards Standardization of Visual Inspection Operator Qualification
  • Understanding Alignment in the Execution of Extractable Screening Studies Between Laboratories: Results of the ELSIE Lab Practices Sub-Team Industry Surveys
Show more Research

Similar Articles

Keywords

  • Cytotoxic drugs
  • Adjuvants
  • Liposomes
  • Drug delivery
  • Bacterial retention
  • Hydrophilic membrane
  • Vaccines
  • MAbs

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire